Insider · CIK 0001913257
Vlad Vitoc
Files at MAIA (MAIA Biotechnology, Inc.). First filing Nov 25, 2025, latest Sep 15, 2026.
In brief
Vlad Vitoc files SEC Form 4 as CEO, director and 10% owner at MAIA (MAIA Biotechnology, Inc.). Since Nov 25, 2025, Vlad Vitoc has reported 7 open-market buys worth $392k and 0 open-market sells worth $0, the latest filed on Sep 15, 2026.
After Vlad Vitoc's past buys, the stock beat the S&P 500 by a median 13.8% over six months (n = 5), and 80% of those buys were ahead of the index at six months. InsiderTell labels that a strong record.
The newest scored trade: bought $100k of MAIA on Sep 14, 2026, filed Sep 15, 2026, scored 54 (moderate). In the last 12 months: 7 buys worth $392k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MAIA: MAIA Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | MAIA Biotechnology, Inc. | $100k 73,000 shares | +7% | +60% from low-53% from high | |
| 61Notable | MAIA Biotechnology, Inc. | $101k 72,700 shares | +8% | +49% from low-56% from high | |
| 65Notable | MAIA Biotechnology, Inc. | $80k 72,000 shares | +9% | +22% from low-57% from high | |
| 53Moderate | MAIA Biotechnology, Inc. | $10k 10,500 shares | +1% | +11% from low-61% from high | |
| 65Notable | MAIA Biotechnology, Inc. | $80k 72,000 shares | +9% | +22% from low-57% from high | |
| 53Moderate | MAIA Biotechnology, Inc. | $10k 10,500 shares | +1% | +11% from low-61% from high | |
| 58Moderate | MAIA Biotechnology, Inc. | $12k 11,800 shares | +1% | +5% from low-63% from high |
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +73,000 | $1.37 | $100k | 1,049,121 | 29 d ago |
| Jun 1, 2026 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +72,700 | $1.39 | $101k | 976,121 | Jun 2, 2026 |
| May 29, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +800,000 | $0.00 | $0 | 800,000 | Jun 1, 2026 |
| Apr 10, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +800,000 | $0.00 | $0 | 800,000 | Apr 14, 2026 |
| Nov 26, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +22,000 | $1.05 | $23k | 853,421 | Dec 4, 2025 |
| Nov 25, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +10,500 | $0.97 | $10k | 831,421 | Dec 4, 2025 |
| Nov 28, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +50,000 | $1.14 | $57k | 903,421 | Dec 4, 2025 |
| Nov 28, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +50,000 | $1.14 | $57k | 881,421 | Dec 1, 2025 |
| Nov 26, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +22,000 | $1.05 | $23k | 853,421 | Dec 1, 2025 |
| Nov 25, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +10,500 | $0.97 | $10k | 831,421 | Nov 28, 2025 |
| Nov 21, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +1,800 | $0.92 | $1,656 | 810,921 | Nov 25, 2025 |
| Nov 24, 2025 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +10,000 | $0.99 | $9,891 | 820,921 | Nov 25, 2025 |
| May 14, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +400,000 | $0.00 | $0 | 400,000 | May 16, 2025 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivative | -19,981 | $1.80 | $36k | 149,519 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivativeindirect: See footnote | +19,981 | $1.80 | $36k | 19,981 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivative | -19,982 | $1.80 | $36k | 129,537 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivativeindirect: See footnote | +19,982 | $1.80 | $36k | 19,982 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivative | -19,982 | $1.80 | $36k | 109,555 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivativeindirect: See footnote | +19,982 | $1.80 | $36k | 19,982 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivative | -41,254 | $2.50 | $103k | 82,506 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivativeindirect: See footnote | +41,254 | $2.50 | $103k | 41,254 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivative | -41,253 | $2.50 | $103k | 41,253 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivativeindirect: See footnote | +41,253 | $2.50 | $103k | 41,253 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivative | -41,253 | $2.50 | $103k | 0 | Nov 7, 2024 |
| Nov 5, 2024 | MAIA MAIA Biotechnology, Inc. | GGift Stock Optionsderivativeindirect: See footnote | +41,253 | $2.50 | $103k | 41,253 | Nov 7, 2024 |
| Jan 24, 2024 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +200,000 | $0.00 | $0 | 200,000 | Jan 26, 2024 |
Questions about Vlad Vitoc
Answered from the filings on this page, as of the latest one.
Is Vlad Vitoc buying or selling?
In the last 12 months Vlad Vitoc reported 7 open-market buys worth $392k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $100k of MAIA on Sep 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Vlad Vitoc's past buys perform?
Measured from the first close after each filing, the stock beat the S&P 500 by a median 13.8% over six months across 5 past buys, with 80% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Vlad Vitoc file Form 4?
Vlad Vitoc has filed Form 4 at MAIA (MAIA Biotechnology, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.